Concepedia
Statistics
Publications
13
Citations
682
H-Index
12
Active since
2014
Affiliations
Washington University in St. Louis(Current)
Sheba Medical Center
The Ohio State University
The University of Texas MD Anderson Cancer Center
University of Alabama at Birmingham
Bethany C. Prudner is an author at Washington University in St. Louis specializing in oncology, molecular oncology, and medicine.
Publications per year
2014–2024
Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers
Jeff C. Kremer, Bethany C. Prudner, Sara Elaine Stubbs Lange et al. · Cell Reports · 2017 · 171 citations · Full text
Life Sciences, Biochemistry, Oncology +17
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma
Kate Lynn J. Bill, Jeannine Garnett, Isabelle Meaux et al. · Clinical Cancer Research · 2015 · 106 citations · Full text
Medicine, Oncology, Pharmacology +14
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas
Gregory R. Bean, Jeff C. Kremer, Bethany C. Prudner et al. · Cell Death and Disease · 2016 · 104 citations · Full text
Medicine, Oncology, Pharmacology +16
Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors
Bethany C. Prudner, Richa Rathore, Anthony M. Robinson et al. · Clinical Cancer Research · 2019 · 65 citations · Full text
Medicine, Oncology, Pharmacology +17
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)
Gonzalo Lopez, Kate Lynn J. Bill, Hemant K. Bid et al. · PLoS ONE · 2015 · 59 citations · Full text
Medicine, Oncology, Pharmacology +13
1–5 of 13